Liu Xiaoping, Wang Yuetong, Ji Hongbin, Aihara Kazuyuki, Chen Luonan
Key Laboratory of Systems Biology, CAS Center for Excellence in Molecular Cell Science, Innovation Center for Cell Signaling Network, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Institute of Industrial Science, University of Tokyo, Tokyo 153-8505, Japan.
Nucleic Acids Res. 2016 Dec 15;44(22):e164. doi: 10.1093/nar/gkw772. Epub 2016 Sep 4.
A complex disease generally results not from malfunction of individual molecules but from dysfunction of the relevant system or network, which dynamically changes with time and conditions. Thus, estimating a condition-specific network from a single sample is crucial to elucidating the molecular mechanisms of complex diseases at the system level. However, there is currently no effective way to construct such an individual-specific network by expression profiling of a single sample because of the requirement of multiple samples for computing correlations. We developed here with a statistical method, i.e. a sample-specific network (SSN) method, which allows us to construct individual-specific networks based on molecular expressions of a single sample. Using this method, we can characterize various human diseases at a network level. In particular, such SSNs can lead to the identification of individual-specific disease modules as well as driver genes, even without gene sequencing information. Extensive analysis by using the Cancer Genome Atlas data not only demonstrated the effectiveness of the method, but also found new individual-specific driver genes and network patterns for various types of cancer. Biological experiments on drug resistance further validated one important advantage of our method over the traditional methods, i.e. we can even identify such drug resistance genes that actually have no clear differential expression between samples with and without the resistance, due to the additional network information.
复杂疾病通常并非由单个分子的功能故障引起,而是由相关系统或网络的功能失调导致,该系统或网络会随时间和条件动态变化。因此,从单个样本估计特定条件下的网络对于在系统层面阐明复杂疾病的分子机制至关重要。然而,由于计算相关性需要多个样本,目前尚无通过单个样本的表达谱构建此类个体特异性网络的有效方法。我们在此开发了一种统计方法,即样本特异性网络(SSN)方法,它使我们能够基于单个样本的分子表达构建个体特异性网络。使用这种方法,我们可以在网络层面表征各种人类疾病。特别是,此类SSN甚至在没有基因测序信息的情况下,也能识别个体特异性疾病模块以及驱动基因。通过使用癌症基因组图谱数据进行的广泛分析不仅证明了该方法的有效性,还发现了各种癌症新的个体特异性驱动基因和网络模式。关于耐药性的生物学实验进一步验证了我们的方法相对于传统方法的一个重要优势,即由于额外的网络信息,我们甚至能够识别在有耐药性和无耐药性样本之间实际上没有明显差异表达的此类耐药基因。